-transparent.png){kind=logo}
This is the first case report of cataracts in patients with thalassemia major. Desferrioxamine, an iron-chelating agent is being used with increasing frequency in the treatment of transfusion-induced iron overload. There has been some concern in the literature about possible cataract formation with use of this drug. It is therefore important to document any lens opacities seen prior to administration of desferrioxamine, or record the appearance of lens opacities after its use. The possible eitology of these lens opacities is discussed.
Related Publications
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
November 1964,
Archives of ophthalmology (Chicago, Ill. : 1960),
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
July 2020,
Indian journal of ophthalmology,
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
January 2011,
European journal of ophthalmology,
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
January 1982,
Vestnik oftalmologii,
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
September 1975,
Ceskoslovenska oftalmologie,
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
March 1988,
Archives of ophthalmology (Chicago, Ill. : 1960),
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
November 1992,
Annals of ophthalmology,
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
October 1983,
Archives of ophthalmology (Chicago, Ill. : 1960),
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
June 1985,
Journal of the American Optometric Association,
S E Bloomfield, and
A L Markenson, and
D R Miller, and
C M Peterson
February 1995,
American journal of epidemiology,
